 2. 5: 50 increase to 10 blasts Note: 30 blasts is considered AML ACUTE MYELOID LEUKEMIAT per FAB FRENCH-AMERICAN BRITISHclassification. Subjects known to have 30 blasts are not eligible for inclusion in this study. RECOG Eastern Cooperative Oncology Group nizing limitations of blast cell quantification, this protocol will allow subjects with pre-enrollment bone marrow blast counts up to 33 on the screening bone marrow examination to be considered for inclusion. Assessment may be made according to local bone marrow examination to facilitate enrollment of eligible subjects into the treatment phase of the study. 